Search

Your search keyword '"Julie A. Marusich"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Julie A. Marusich" Remove constraint Author: "Julie A. Marusich"
64 results on '"Julie A. Marusich"'

Search Results

1. Δ9-tetrahydrocannabinol discrimination: Effects of route of administration in mice

3. Xylazine co-self-administration suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats

4. Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development

5. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism

6. Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats

7. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists

8. Strain and sex matters: Differences in nicotine self-administration between outbred and recombinase-driver transgenic rat lines

9. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists

10. Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats

11. Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats

12. Economic demand analysis of within-session dose-reduction during nicotine self-administration

13. Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats

14. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice

15. Pharmacological effects of methamphetamine and alpha-PVP vapor and injection

16. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue

17. Nicotine reduction does not alter essential value of nicotine or reduce cue-induced reinstatement of nicotine seeking

18. Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats

19. Synthetic cathinone self-administration in female rats modulates neurotransmitter levels in addiction-related brain regions

21. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA

22. Tobacco's minor alkaloids: Effects on place conditioning and nucleus accumbens dopamine release in adult and adolescent rats

23. Evaluation of sex differences in cannabinoid dependence

24. Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model

25. Erratum to 'Economic demand analysis of within-session dose-reduction during nicotine self-administration' [Drug Alcohol Depend. 201 (2019) 188–196]

26. Comparison of cigarette, little cigar, and waterpipe tobacco smoke condensate and e-cigarette aerosol condensate in a self-administration model

27. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences

28. Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids

29. Comparison of the discriminative stimulus and response rate effects of

30. Combination Chemistry: Structure–Activity Relationships of Novel Psychoactive Cannabinoids

31. Environmental enrichment during development decreases intravenous self-administration of methylphenidate at low unit doses in rats

32. Effects of synthetic cathinones contained in 'bath salts' on motor behavior and a functional observational battery in mice

33. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)

34. Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure

35. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety

36. Escalation of cocaine intake with extended access in rats: dysregulated addiction or regulated acquisition?

37. Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder

38. Cue effects on methylphenidate self-administration in rats

39. Novelty seeking, incentive salience and acquisition of cocaine self-administration in the rat

40. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol–Like Effects in Mice

41. The impact of gonadal hormones on cannabinoid dependence

42. Stability of cocaine dose–response functions at different inter-dose intervals

43. Effects of α‐Pyrrolidinopentiophenone and 4-Methyl-N-Ethylcathinone, Two Synthetic Cathinones Commonly Found in Second-Generation 'Bath Salts,' on Intracranial Self-Stimulation Thresholds in Rats

45. Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice

46. Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

47. Determination of behaviorally effective tobacco constituent doses in rats

48. Cross-Substitution of Δ9-Tetrahydrocannabinol and JWH-018 in Drug Discrimination in Rats

49. Pharmacology of novel synthetic stimulants structurally related to the 'bath salts' constituent 3,4-methylenedioxypyrovalerone (MDPV)

50. The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in 'Bath Salts'

Catalog

Books, media, physical & digital resources